Abstract | BACKGROUND: AIM: In stable heart patients from primary care, to examine neuroendocrine markers of cardiac performance for the association to cardiac dysfunction, morbidity and mortality. METHODS: RESULTS: The study included 56 patients. Mean age was 71 years, 54% were men, 43% had clinical signs of CHF, 39 + 52 + 9% were in NYHA I + II + III, 34% had echocardiographic cardiac dysfunction, and 18 died during follow-up. N- ANP was related to all subtypes of cardiac dysfunction (p < 0.05). Catecholamines and premature ventricular captures ( PVC) were related to valvular and systolic dysfunction, but heart rate variability and dipping blood pressure were not (p > 0.05). On multivariate analyses only, N- ANP and PVC were associated with clinical signs of CHF, echocardiographic cardiac dysfunction, and mortality (p < 0.05). CONCLUSIONS: Plasma N- ANP was stronger than catecholamines and variables of 24-h monitoring (blood pressure and electrocardiogram) in predicting morbidity and mortality, thereby supporting the use of cardiac natriuretic peptides (i.e. N- ANP, BNP, or N-BNP) as the most valuable biomarker in community patients at risk of CHF.
|
Authors | O W Nielsen, V Rasmussen, N J Christensen, J F Hansen |
Journal | Scandinavian journal of clinical and laboratory investigation
(Scand J Clin Lab Invest)
Vol. 64
Issue 7
Pg. 619-28
( 2004)
ISSN: 0036-5513 [Print] England |
PMID | 15513318
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- N-terminal proatrial natriuretic peptide
- Protein Precursors
- Atrial Natriuretic Factor
- Norepinephrine
- Epinephrine
|
Topics |
- Adult
- Aged
- Atrial Natriuretic Factor
(blood)
- Community Health Services
- Epinephrine
(blood)
- Female
- Heart Diseases
(diagnosis, epidemiology, mortality)
- Heart Failure
(diagnosis)
- Heart Rate
(physiology)
- Humans
- Male
- Middle Aged
- Morbidity
- Norepinephrine
(blood)
- Prognosis
- Protein Precursors
(blood)
- Severity of Illness Index
|